» Authors » Pablo Hock

Pablo Hock

Explore the profile of Pablo Hock including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 341
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Blanchard M, Sigmon J, Brennan J, Ahulamibe C, Allen M, Ardery S, et al.
G3 (Bethesda) . 2024 Sep; 14(10). PMID: 39271181
The MiniMUGA genotyping array is a popular tool for genetic quality control of laboratory mice and genotyping samples from most experimental crosses involving laboratory strains, particularly for reduced complexity crosses....
2.
Leist S, Schafer A, Risemberg E, Bell T, Hock P, Zweigart M, et al.
Virus Res . 2024 Jun; 346:199399. PMID: 38823688
Coronaviruses have caused three severe epidemics since the start of the 21 century: SARS, MERS and COVID-19. The severity of the ongoing COVID-19 pandemic and increasing likelihood of future coronavirus...
3.
Risemberg E, Smeekens J, Cruz Cisneros M, Hampton B, Hock P, Linnertz C, et al.
J Allergy Clin Immunol . 2024 Apr; 154(2):387-397. PMID: 38670234
Background: The development of peanut allergy is due to a combination of genetic and environmental factors, although specific genes have proven difficult to identify. Previously, we reported that peanut-sensitized Collaborative...
4.
Schafer A, Marzi A, Furuyama W, Catanzaro N, Nguyen C, Haddock E, et al.
Cell Rep . 2024 Apr; 43(5):114127. PMID: 38652660
Ebola virus (EBOV), a major global health concern, causes severe, often fatal EBOV disease (EVD) in humans. Host genetic variation plays a critical role, yet the identity of host susceptibility...
5.
Schafer A, Gralinski L, Leist S, Hampton B, Mooney M, Jensen K, et al.
Virus Res . 2024 Mar; 344:199357. PMID: 38508400
Coronavirus (CoV) cause considerable morbidity and mortality in humans and other mammals, as evidenced by the emergence of Severe Acute Respiratory CoV (SARS-CoV) in 2003, Middle East Respiratory CoV (MERS-CoV)...
6.
Graham J, Swarts J, Leist S, Schafer A, Bell T, Hock P, et al.
iScience . 2024 Feb; 27(3):109103. PMID: 38361611
The response to infection is generally heterogeneous and diverse, with some individuals remaining asymptomatic while others present with severe disease or a diverse range of symptoms. Here, we address the...
7.
Cruz Cisneros M, Anderson E, Hampton B, Parotti B, Sarkar S, Taft-Benz S, et al.
Vaccines (Basel) . 2024 Jan; 12(1). PMID: 38276675
The COVID-19 pandemic led to the rapid and worldwide development of highly effective vaccines against SARS-CoV-2. However, there is significant individual-to-individual variation in vaccine efficacy due to factors including viral...
8.
Risemberg E, Smeekens J, Cruz Cisneros M, Hampton B, Hock P, Linnertz C, et al.
bioRxiv . 2023 Sep; PMID: 37745496
Background: The development of peanut allergy is due to a combination of genetic and environmental factors, although specific genes have proven difficult to identify. Previously, we reported that peanut-sensitized CC027/GeniUnc...
9.
Faber J, Zhang H, Xenakis J, Bell T, Hock P, Pardo-Manuel de Villena F, et al.
J Cereb Blood Flow Metab . 2023 Aug; 43(11):1983-2004. PMID: 37572089
Collateral blood flow varies greatly among humans for reasons that remain unclear, resulting in significant differences in ischemic tissue damage. A similarly large variation has also been found in mice...
10.
Faber J, Zhang H, Xenakis J, Bell T, Hock P, Pardo-Manuel de Villena F, et al.
bioRxiv . 2023 Jul; PMID: 37398475
Collateral blood flow varies greatly among humans for reasons that remain unclear, resulting in significant differences in ischemic tissue damage. A similarly large variation has also been found in mice...